Google Alert - "Myeloproliferative neoplasms" OR "polycythemia vera" OR myelofibrosis OR "essential thrombocythemia" · Scour

CERo Therapeutics Doses Second Patient in Cohort 2 of Phase 1 CER-1236 Trial

The OncFive: Top Oncology Articles for the Week of 3/22

Fairvoy Private Wealth Boosts Incyte Corporation Holdings

Early Results Demonstrate Safety and Efficacy of Mutant Calreticulin–Specific Monoclonal ...

Myeloproliferative neoplasms with concomitant chronic myeloid leukemia are associated ...

Selective BET Inhibition With ABBV-744 Shows Early Clinical Activity in Myelofibrosis

Stem cell therapy for autism illegal: NMC advisory

ASH 2025: Myelofibrosis Roundup

KPTI Stock Down on Mixed Phase III Myelofibrosis Combo Study Data

KPTI Shares Fall Following Varied Results from Phase III Myelofibrosis Combination Study

Karyopharm Slides as Mixed Myelofibrosis Results Cloud Regulatory Road

KPTI stock slumps pre-market even as Karyopharm's myelofibrosis treatment meets primary endpoint

Karyopharm posts split readout for Xpovio in myelofibrosis study

Phase 3 SENTRY Trial Shows Selinexor Reduces Spleen Volume in Myelofibrosis Patients

Protagonist Therapeutics stock surges on FDA approval of key drug partnership with J&J ...

Karyopharm Therapeutics Inc. (KPTI) Discusses Top Line Results From Phase III SENTRY ...

Karyopharm's drug meets one of two goals in blood cancer trial

Myelofibrosis Drug Development Surges: 40+ Pipeline Candidates Across 35+ Companies ...

Log in to enable infinite scrolling